FGEN Fibrogen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: FGEN

Price (delayed)

$1.145

Market cap

$113.9M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.45

Enterprise value

$210.34M

FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing, and commercializing a pipeline of first-in-class therapeutics. The Company applies its pioneering expertise in hypoxia-inducible factor (HIF) and connective tissue ...

Highlights
The company's revenue rose by 44% YoY and by 13% QoQ
FGEN's gross profit is up by 31% year-on-year
The company's debt rose by 50% YoY
The quick ratio has contracted by 26% YoY and by 4.4% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.fibrogen.com
Peers: ILMN A HBIO PACB

Key stats

What are the main financial stats of FGEN
Market
Shares outstanding
99.48M
Market cap
$113.9M
Enterprise value
$210.34M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.26
Earnings
Revenue
$167.49M
EBIT
-$222.34M
EBITDA
-$214.56M
Free cash flow
-$274.68M
Per share
EPS
-$2.45
Free cash flow per share
-$2.77
Book value per share
-$2.31
Revenue per share
$1.69
TBVPS
$3.7
Balance sheet
Total assets
$365.87M
Total liabilities
$552.02M
Debt
$202.17M
Equity
-$228.12M
Working capital
$81.43M
Liquidity
Debt to equity
-0.89
Current ratio
1.41
Quick ratio
1.09
Net debt/EBITDA
-0.45
Margins
EBITDA margin
-128.1%
Gross margin
75.5%
Net margin
-143.6%
Operating margin
-141.4%
Efficiency
Return on assets
-54.5%
Return on equity
N/A
Return on invested capital
-70.2%
Return on capital employed
-131.5%
Return on sales
-132.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

FGEN stock price

How has the Fibrogen stock price performed over time
Intraday
-6.91%
1 week
9.05%
1 month
9.05%
1 year
-38.77%
YTD
29.19%
QTD
28.65%

Financial performance

How have Fibrogen's revenue and profit performed over time
Revenue
$167.49M
Gross profit
$126.38M
Operating income
-$236.79M
Net income
-$240.46M
Gross margin
75.5%
Net margin
-143.6%
Fibrogen's operating margin has increased by 48% YoY and by 26% from the previous quarter
The company's net margin rose by 46% YoY and by 25% QoQ
The company's revenue rose by 44% YoY and by 13% QoQ
FGEN's gross profit is up by 31% year-on-year

Growth

What is Fibrogen's growth rate over time

Valuation

What is Fibrogen stock price valuation
P/E
N/A
P/B
N/A
P/S
0.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.26
The company's EPS rose by 25% YoY and by 16% QoQ
FGEN's equity is down by 12% since the previous quarter
The stock's price to sales (P/S) is 93% less than its 5-year quarterly average of 10.9 and 34% less than its last 4 quarters average of 1.1
The company's revenue rose by 44% YoY and by 13% QoQ

Efficiency

How efficient is Fibrogen business performance
The company's return on sales rose by 49% YoY and by 27% QoQ
FGEN's return on invested capital is up by 30% year-on-year and by 19% since the previous quarter
FGEN's return on assets is down by 8% year-on-year but it is up by 7% since the previous quarter

Dividends

What is FGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FGEN.

Financial health

How did Fibrogen financials performed over time
FGEN's total assets is 34% smaller than its total liabilities
FGEN's total assets is down by 32% year-on-year and by 14% since the previous quarter
The quick ratio has contracted by 26% YoY and by 4.4% from the previous quarter
The company's debt is 189% higher than its equity
FGEN's debt to equity has soared by 55% YoY and by 11% from the previous quarter
The company's debt rose by 50% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.